NDAINTRAVENOUSSOLUTION
Approved
Apr 2008
Lifecycle
LOE Approaching
Competitive Pressure
25/100
Clinical Trials
20
Mechanism of Action
Adenosine Receptor Agonists
Pharmacologic Class:
Adenosine Receptor Agonist
Clinical Trials (5)
Use of Lexiscan for Myocardial Stress Perfusion Computed Tomography With a 3rd Generation Dual Source CT System
Started Feb 2016
24 enrolled
Cardiovascular DiseasesCoronary Artery Disease
Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking
Started Sep 2014
Ischemia
Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension
Started Aug 2014
10 enrolled
Pulmonary Hypertension
Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects
Started May 2013
36 enrolled
Healthy Volunteers
Heart Rate Response to Regadenoson and Sudden Cardiac Death
Started Feb 2013
Left Ventricular Systolic DysfunctionSudden Cardiac Death
Loss of Exclusivity
LOE Date
Feb 2, 2027
11 months away
Patent Expiry
Feb 2, 2027
Company
Astellas
China - Shenyang